Advertisement
Advertisement
BNGO
Bionano Genomics, Inc. Common Stock
1.09
USDSponsored
0.00
0.00%
Jul 29, 15:59 UTC -4
Closed
After-Market
1.06
-0.03
-2.29%
BNGO Earnings Reports
Positive Surprise Ratio
BNGO beat 12 of 31 last estimates.
39%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.63M
/-$0.69
Implied change from Q1 26 (Revenue/ EPS)
+14.03%
/-9.21%
Implied change from Q2 25 (Revenue/ EPS)
+13.26%
/-65.33%
Bionano Genomics, Inc. Common Stock earnings per share and revenue
On May 13, 2026, BNGO reported earnings of -0.76 USD per share (EPS) for Q1 26, beating the estimate of -0.89 USD, resulting in a 15.33% surprise. Revenue reached 6.69 million, compared to an expected 6.70 million, with a -0.18% difference. The market reacted with a -4.80% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.69 USD, with revenue projected to reach 7.63 million USD, implying an decrease of -9.21% EPS, and increase of 14.03% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Biogen Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$3.05
Actual
$3.60
Surprise
+17.99%
Repligen Corp
Report Date
Jul 28, 2026 For Q2 26
Estimate
$0.45
Actual
$0.54
Surprise
+18.01%
Viking Therapeutics, Inc
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$1.27
Actual
-$1.10
Surprise
+13.52%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+26.69%
NeoGenomics, Inc.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$0.03
Actual
$0.05
Surprise
+51.06%
uniQure N.V.
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.84
Actual
-$1.22
Surprise
-45.12%
Fortrea Holdings Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.18
Actual
$0.23
Surprise
+24.93%
MiMedx Group, Inc
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.05
Surprise
-3.09%
Nautilus Biotechnolgy, Inc. Common Stock
Report Date
Jul 28, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.11
Surprise
+20.12%
Amarin Corp Plc
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.01
Actual
$0.04
Surprise
+492.16%
FAQ
What were Bionano Genomics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Bionano Genomics, Inc. Common Stock reported EPS of -$0.76, beating estimates by 15.33%, and revenue of $6.69M, -0.18% below expectations.
How did the market react to Bionano Genomics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -4.8%, changed from $1.25 before the earnings release to $1.19 the day after.
When is Bionano Genomics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Bionano Genomics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Bionano Genomics, Inc. Common Stock is expected to report EPS of -$0.69 and revenue of $7.63M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement